La EMA ha publicado el 28 de abril de 2016 una nueva guía borrador sobre las buenas prácticas de farmacogenómica
EMA/CHMP/268544/2016. Committee for Medicinal Products for Human Use (CHMP)
Draft guideline on good pharmacogenomic practice.
The aim of this guideline is to lay out the requirements related to the choice of appropriate genomic methodologies during the development and life-cycle of a drug.
Consulta la GUÍA